» Articles » PMID: 12453409

REDD1, a Developmentally Regulated Transcriptional Target of P63 and P53, Links P63 to Regulation of Reactive Oxygen Species

Overview
Journal Mol Cell
Publisher Cell Press
Specialty Cell Biology
Date 2002 Nov 28
PMID 12453409
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

We identified REDD1 as a novel transcriptional target of p53 induced following DNA damage. During embryogenesis, REDD1 expression mirrors the tissue-specific pattern of the p53 family member p63, and TP63 null embryos show virtually no expression of REDD1, which is restored in mouse embryo fibroblasts following p63 expression. In differentiating primary keratinocytes, TP63 and REDD1 expression are coordinately downregulated, and ectopic expression of either gene inhibits in vitro differentiation. REDD1 appears to function in the regulation of reactive oxygen species (ROS); we show that TP63 null fibroblasts have decreased ROS levels and reduced sensitivity to oxidative stress, which are both increased following ectopic expression of either TP63 or REDD1. Thus, REDD1 encodes a shared transcriptional target that implicates ROS in the p53-dependent DNA damage response and in p63-mediated regulation of epithelial differentiation.

Citing Articles

Isowalsuranolide targets TrxR1/2 and triggers lysosomal biogenesis and autophagy via the p53-TFEB/TFE3 axis.

Yang X, Ding X, Zhao Y, Wang Y, Dong X, Niu Z Sci China Life Sci. 2025; .

PMID: 40059270 DOI: 10.1007/s11427-023-2563-6.


Increased nuclear expression of DNA damage inducible transcript 4 can serve as a potential prognostic biomarker in patients with gliomas: a study based on data mining and experimental tools.

Sadeghipour A, Fattahi F, Madjd Z, Tajik F, Sedaghati F, Saeednejad Zanjani L Discov Oncol. 2025; 16(1):124.

PMID: 39915428 PMC: 11802953. DOI: 10.1007/s12672-025-01865-0.


REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity.

Carew J, Espitia C, Sureshkumar S, Carrera Espinoza M, Gamble M, Wang W Cancer Lett. 2025; 613:217496.

PMID: 39892703 PMC: 11832319. DOI: 10.1016/j.canlet.2025.217496.


Development and validation of disulfidptosis-related genes signature for patients with glioma.

Wang J, Luo J, Yang S, Deng Y, Chen P, Tan Y Discov Oncol. 2024; 15(1):758.

PMID: 39692962 PMC: 11655816. DOI: 10.1007/s12672-024-01664-z.


RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer's disease.

Campoy-Campos G, Solana-Balaguer J, Guisado-Corcoll A, Chicote-Gonzalez A, Garcia-Segura P, Perez-Sisques L Nucleic Acids Res. 2024; 52(18):11158-11176.

PMID: 39268577 PMC: 11472047. DOI: 10.1093/nar/gkae776.